Switch to: References

Add citations

You must login to add citations.
  1. The Invisible Patient: Concerns about Donor Exploitation in Stem Cell Research.Pär Segerdahl - 2022 - Health Care Analysis 30 (3):240-253.
    As embryonic stem cell research is commercialized, the stem cell debate may shift focus from concerns about embryo destruction to concerns about exploitation of the women who donate eggs and embryos for research. Uncomfortable with the polarization of the embryo debate, this paper proposes a more “contemplative” approach than intellectual debate to concerns about exploitation. After examining pitfalls of rigid intellectual positions on exploitation, the paper investigates the possibility of a broader understanding of donation for research where patients are seen (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Accelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy Catapult.Andrew Webster & John Gardner - 2017 - Science, Technology, and Human Values 42 (5):925-946.
    The field of regenerative medicine has considerable therapeutic promise that is proving difficult to realize. As a result, governments have supported the establishment of intermediary agencies to “accelerate” innovation. This article examines in detail one such agency, the United Kingdom’s Cell and Gene Therapy Catapult. We describe CGTC’s role as an accelerator agency and its value narrative, which combines both “health and wealth.” Drawing on the notion of sociotechnical imaginaries, we unpack the tensions within this narrative and its instantiation as (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation